secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-08-05T12:55:18+00:00
Accession:  0001493152-26-036112
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions completes usability study for FDA 510(k) submission for drug screening system
--------------------------------------------------------------------------------

- Study confirms system can be effectively administered by operators with no specialist background.
- Study conducted with CenExel Clinical Research; 15 operators participated.
- On track to submit 510(k) package in H2 2026 for U.S. market clearance for opiate codeine detection.
- Part of broader submission program including cut-off, method comparison, interference, and precision studies.
- Targets entry into the multi-billion-dollar U.S. drug screening market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226036112/0001493152-26-036112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226036112/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer